Integrated BioPharma (OTCMKTS:INBP) Stock Price Up 16%
Shares of Integrated BioPharma, Inc. (OTCMKTS:INBP) rose 16% on Tuesday . The company traded as high as $0.29 and last traded at $0.29, approximately 20,000 shares changed hands during trading. An increase of 212% from the average daily volume of 6,413 shares. The stock had previously closed at $0.25.
The company’s 50 day simple moving average is $0.23. The stock has a market capitalization of $8.51 million, a P/E ratio of 3.13 and a beta of -0.90. The company has a quick ratio of 0.40, a current ratio of 1.13 and a debt-to-equity ratio of 4.60.
Integrated BioPharma (OTCMKTS:INBP) last released its earnings results on Wednesday, May 15th. The company reported $0.03 EPS for the quarter. The company had revenue of $14.09 million during the quarter. Integrated BioPharma had a negative return on equity of 240.18% and a net margin of 3.91%.
Integrated Biopharma, Inc, together with its subsidiaries, manufactures, distributes, markets, and sells vitamins, nutritional supplements, and herbal products primarily in the United States, Luxembourg, and Canada. It operates through three segments: Contract Manufacturing, Branded Proprietary Products, and Other Nutraceutical Businesses.
Featured Article: What does RSI mean?
Receive News & Ratings for Integrated BioPharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Integrated BioPharma and related companies with MarketBeat.com's FREE daily email newsletter.